Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute Milan, Italy.
Front Immunol. 2013 Jan 28;4:9. doi: 10.3389/fimmu.2013.00009. eCollection 2013.
Endometriosis, a common cause of pelvic pain and female infertility, depends on the growth of vascularized endometrial tissue at ectopic sites. Endometrial fragments reach the peritoneal cavity during the fertile years: local cues decide whether they yield endometriotic lesions. Macrophages are recruited at sites of hypoxia and tissue stress, where they clear cell debris and heme-iron and generate pro-life and pro-angiogenesis signals. Macrophages are abundant in endometriotic lesions, where are recruited and undergo alternative activation. In rodents macrophages are required for lesions to establish and to grow; bone marrow-derived Tie-2 expressing macrophages specifically contribute to lesions neovasculature, possibly because they concur to the recruitment of circulating endothelial progenitors, and sustain their survival and the integrity of the vessel wall. Macrophages sense cues (hypoxia, cell death, iron overload) in the lesions and react delivering signals to restore the local homeostasis: their action represents a necessary, non-redundant step in the natural history of the disease. Endometriosis may be due to a misperception of macrophages about ectopic endometrial tissue. They perceive it as a wound, they activate programs leading to ectopic cell survival and tissue vascularization. Clearing this misperception is a critical area for the development of novel medical treatments of endometriosis, an urgent and unmet medical need.
子宫内膜异位症是一种常见的盆腔疼痛和女性不孕的原因,它依赖于血管化的子宫内膜组织在异位部位的生长。在生育期,子宫内膜碎片会到达腹腔:局部线索决定它们是否会产生子宫内膜异位症病变。在缺氧和组织应激部位,巨噬细胞被招募,清除细胞碎片和血红素铁,并产生促进生存和血管生成的信号。巨噬细胞在子宫内膜异位症病变中大量存在,它们被招募并发生替代激活。在啮齿动物中,巨噬细胞是病变形成和生长所必需的;骨髓来源的表达 Tie-2 的巨噬细胞特异性地促进病变新生血管形成,可能是因为它们有助于募集循环内皮祖细胞,并维持其存活和血管壁的完整性。巨噬细胞在病变中感知到缺氧、细胞死亡、铁过载等线索,并发出信号以恢复局部内稳态:它们的作用是疾病自然史中的一个必要的、非冗余步骤。子宫内膜异位症可能是由于巨噬细胞对异位子宫内膜组织的错误感知。它们将其视为创伤,激活导致异位细胞存活和组织血管生成的程序。消除这种错误感知是开发子宫内膜异位症新的医学治疗方法的关键领域,这是一个迫切和未满足的医学需求。